key: cord-0775680-y69ebdxo authors: Charley, B.; Laude, H.; La Bonnardière, C. title: Inhibition of transmissible gastroenteritis coronavirus (TGEV) multiplication in vitro by non-immune lymphocytes date: 1987-06-30 journal: Annales de l'Institut Pasteur / Virologie DOI: 10.1016/s0769-2617(87)80003-5 sha: 67c9915e9aaaeed5cdfb8164a0bf9dbbb881722d doc_id: 775680 cord_uid: y69ebdxo Summary In vitro studies were undertaken to examine the effects of non-immune porcine peripheral blood leukocytes (PBL) on a Coronavirus infection due to transmissible gastroenteritis virus (TGEV). The assay consisted of TGEV-infected epithelial cells expressing viral antigens on the cell surface and producing low amounts of interferon (IFN). Non-immune PBL were found to limit virus replication at an effector-to-target ratio of 100/1 even when effector cells were depleted of phagocytic cells. Neutralizing anti-IFN antibodies did not abrogate the effect. PBL from newborn animals were as effective as adult cells, whereas fibroepithelial cells, human and mouse lymphoid cells did not exert antiviral effects. Under similar conditions, PBL from adult animals could lyse TGEV-infected cells even in the presence of anti-IFN antibodies. However, newborn PBL were not cytotoxic. Moreover, depletion of NK cells by monoclonal antibodies plus complement did not alter the inhibitory effect. These latter observations suggest that virus multiplication-inhibition effects and cytotoxic (or NK) activities are unrelated. Non-specific defence mechanisms against viral infections include interferon (IFN) production and cell-mediated reactions. Non-immune mononuclear cells have been shown to counteract virus spreading by at least three distinct mechanisms: IFN production, spontaneous lysis of virus-infected cells (or natural killing, NK [14, 33] ) and inhibition of virus replication [26] . In some cases, such as MHV3 or HSV 1 infections, the great susceptibility of young animals was correlated with their immature cell-mediated immune reactions [16, 32] . In the present report, we have studied transmissible gastroenteritis virus (TOBV), a coronavirus which induces fatal diarrhoeas in up to 100 % of infected newborn piglets [12] . We show that non-immune porcine blood leukocytes (PBL) can inhibit TGEV multiplication in vitro. This inhibitory effect is an early mechanism which seems unrelated to the cytotoxic functions of PBL. In addition, both activities (inhibition of replication and cellmediated cytotoxicity) appeared to be independent of IFNa production. \Ve used conventionally reared pigs obtained from a herd with no history of TOE and lacking neutralizing anti-TOEV serum antibodies. As a source of TOBV, we used the cell-adapted Purdue 115 strain. Methods for propagation and titration (plaque-forming units, or PFU) were as already described [20] . Peripheral blood leukocytes (PBL) were obtained from heparinized blood by Ficoll density centrifugation [8, 29] by iron carbonyl ingestion [29] followed by centrifugation on lymphoprep (Nyegaard, Oslo, Norway). The epithelial pig kidney cell line RPTG was cultured as previously described [20] . Mouse thyrnocytes were obtained from BALB/c mice raised in our own facilities. SP 2 0 mouse myeloma cells were provided by J. Grosclaude (INRA, Thiverval-Grignon) . Human rectum carcinoma cells (HRT-18) and simian kidney cells (MA-I04) were obtained from J.F. Vautherot (INRA, Thiverval-Grignon) . Human erythroleukaemia K562 cells were grown in suspension in RPMI supplemented with 10 070 foetal calf serum (FCS). IFN was assayed on bovine MDBK cells using vesicular stomatitis virus as a challenge [18] . In this assay system, our laboratory unit (U) is equal to 0.25 international units of human IFNcx. Anti-human IFNa. antiserum was kindly provided by C. Chany (INSERM, Paris); it was absorbed on porcine PBL and used at a final dilution of 1/300, which neutralized at least 98 lifo of porcine IFN present in these experiments (table I) . Control experiments showed that this antiserum was devoid of anti-TGEV antibodies and did not inhibit TGEV replication in RPTG cells. Cell-mediated inhibition assay of virus multiplication. RPTG cells were plated for 24 h in 25 cm 2 tissue culture flasks (2 X 10 6 cells per flask). Cells were then washed and infected with TGEV for 1 h in serum-free minimal essential medium (MEM) at a multiplicity of infection (m.o.i.) of 2. Cultures were then incubated at 38°C overnight in MEME supplemented with 10 % normal calf serum (NCS) , tr ypsinized and washed. RPTG cells (10 4 ) were incubated with 10 6 PBL (effector-to-target (BIT) ratio of 100/1, unless otherwise stated) in a final volume of 200 [1.1 (RPMI + 10 % FCS) in wells of round-bottomed microtitre plates (Nunc, Roskild, Denmark) for 22 h. Plates were then frozen and thawed in order to titrate together free and cell-associated TGEV. Controls included infected RPTG cells in the absence of PBL. Cell-mediated cytotoxicity against virus-infected cells: 75Se-release assay. TGEV-infected RPTG cells were obtained as stated above except that, during overnight incubation, cells were labelled with 75-selenomethionine [24] ; 1 fLCi (4 Ci/mmol; Amersham, UK) for 10 5 cells in methionine-free RPMI medium (Eurobio, Paris) supplemented with 10 % NCS. Trypsinized cells were extensively washed and added to PBL at different EIT ratios, in a final volume of 200 fLI (RPMI + 10 % FCS) for 22 h (unless otherwise stated). Control exper iments were performed with non-infected labeIled RPTG cells. At the end of the assay, plates were centrifuged (300 g for 10 min) and 100 [1. 1 sa mples of supernatant were collected for radioactivity measurement. Percent cytotoxicity was calculated as: 100 X (cpm exp -cpm SR)/{cpm MR -cpm SR) where SR (spontaneous release) relates to labelled cells in the absence of PBL, and MR (maximal release) to cells with 10 % Triton-X100. Cell-mediated cytotoxicity against K562 cells: 51Cr-rclease assay. A 4-h 51 Cr-release assay was performed as previously described [6] in roundbottomed cultu re plates with 10 4 K562 cells added to various effector cell dilutions. The % cytotoxicity was calculated as stated above. Complement-dependent cytolysis. Non-toxic one-month old rabbit sera served as a source of complement. One volume of PBL (3-10 x 10 6 cells per ml) was mixed with one volume of complement (1115 final dilution) and three volumes of antibodies for 30 min at 37°C [28] . Then, the residual cell viability was measured by Trypan blue dye exclusion and the cells were assayed after readjustment of the viable cell concentration. Anti-porcine PBL hybridomas 76- 2-11, 76-7-4 [27] and MSA4 [13] were kindly provided by Dr M. Pescovitz (NIH), and the corresponding monoclonal antibodies (MoAb) were used as ascitic fluids at a final dilution of 11200. Several experiments indicated that viral antigens were expressed on the surface of TGEV-infected cells: by performing antibody-dependent cellmediated cytotoxicity (ADCC) assays, a higher cytotoxicity was obtained when infected target cells were incubated with porcine PBL in the presence of anti-TOEV antiserum [7] . Surface immunofluorescence assays were also performed on RPTO cells trypsinized 16 h after infection using monoclonal antibodies directed against viral glycoprotein E z . Most cells expressed surface antigens (data not shown) as also shown on cell monolayers [22] . Under these conditions, infected RPTG cells produced very low IFN amounts (less than 10 V/ml) within 22 h. In contrast, supernatants of infected RPTG cells incubated for 22 h with porcine PBL contained IFN with titres ranging from 100 to 800 Vlml. The leukocytic origin of this IFN was confirmed by the fact (table I) that it was almost completely neutralized by an anti-human IFN